 |
PDBe Entry: 2f89 
Crystal structure of human FPPS in complex with pamidronate
 |
TRANSFERASE
|
|
X-RAY DIFFRACTION
|
|
Resolution: 2.6 Å, R-factor: 20.6%, Free R-factor: 26.7%, Spacegroup: P 41 21 2
|
|
28/02/2006, deposition: 02/12/2005, last revision: 24/02/2009
|
Rondeau, J.-M. ; Bitsch, F. ; Bourgier, E. ; Geiser, M. ; Hemmig, R. ; Kroemer, M. ; Lehmann, S. ; Ramage, P. ; Rieffel, S. ; Strauss, A. ; Green, J.R. ; Jahnke, W.
|
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs. CHEMMEDCHEM vol:1, pag:267-273 (2006) [PubMed ID 16892359 ]
|
MEVALONATE PATHWAY; ISOPRENE BIOSYNTHESIS; CHOLESTEROL BIOSYNTHESIS; BISPHOSPHONATE INHIBITOR , TRANSFERASE
|
2.5.1.1 ExPASy BRENDA 2.5.1.10 ExPASy BRENDA (F)
|
Homo sapiens(human) 9606 (F)
|
Farnesyl pyrophosphate synthetase (FPP synthetase) (FPS) (Farnesyl diphosphate synthetase) [Includes: Dimethylallyltranstransferase (EC 2.5.1.1); Geranyltranstransferase (EC 2.5.1.10)] P14324 (F)
|
|
F
|
|
2f7m, 2f8c, 2f8z, 2f92, 2f94, 2f9k
|
| F |
Farnesyl Diphosphate Synthase |
Protein |
P14324 (FPPS_HUMAN)
|
350 |
98% |
|
| F |
PHOSPHATE ION |
PO4
 |
| F |
MANGANESE (II) ION |
MN
 |
| F |
PAMIDRONATE |
210
 |
|
|